From the FDA Drug Label
In cancer chemotherapy patients being treated with 1 to 2 mg/kg per dose, incidence of drowsiness is about 70% There are isolated reports of convulsive seizures without a clear-cut relationship to metoclopramide.
- Metoclopramide and epilepsy: There are isolated reports of convulsive seizures, but no clear-cut relationship to metoclopramide has been established 1.
- Key points:
- Isolated reports of convulsive seizures
- No clear-cut relationship to metoclopramide established
- Use with caution in patients with a history of seizures or epilepsy.
From the Research
Metoclopramide should be used with caution in patients with epilepsy as it may increase the risk of seizures. For epileptic patients who require an antiemetic, metoclopramide should be used at the lowest effective dose (typically 5-10 mg up to three times daily) for the shortest duration possible, with close monitoring for seizure activity. Alternative antiemetics such as ondansetron or domperidone may be safer options for epileptic patients when appropriate. The seizure risk with metoclopramide is due to its dopamine antagonist properties which can lower the seizure threshold by affecting neurotransmitter balance in the brain. This risk is dose-dependent and more pronounced in patients with poorly controlled epilepsy, those with electrolyte disturbances, or those taking other medications that lower seizure threshold. If metoclopramide must be used in an epileptic patient, ensure that antiepileptic medications are optimized and maintained at therapeutic levels, such as carbamazepine, lamotrigine, or levetiracetam, which have been shown to be effective in managing epilepsy 2. Any new or worsening seizure activity during metoclopramide treatment should prompt immediate discontinuation of the medication.
Some key points to consider when managing epilepsy include:
- The use of antiepileptic medications, such as carbamazepine, lamotrigine, or levetiracetam, which have been shown to be effective in managing epilepsy 2
- The potential for drug interactions, such as those between antiepileptic medications and other medications that may lower the seizure threshold 3
- The importance of monitoring for adverse events, such as seizure activity, and adjusting treatment accordingly 2
- The potential benefits of using alternative antiemetics, such as ondansetron or domperidone, in patients with epilepsy who require antiemetic therapy 4, 5
It is also important to note that the management of epilepsy is complex and requires individualized treatment plans, taking into account the specific needs and circumstances of each patient. As such, it is essential to stay up-to-date with the latest evidence and guidelines, such as those provided by the Continuum issue on epilepsy 4, 5, in order to provide optimal care for patients with epilepsy.